Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin Attenuates Sorafenib-Induced Myocardial Inflammation and Toxicity

“Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin Attenuates Sorafenib-Induced Myocardial Inflammation and Toxicity”. 2024. Environmental Toxicology 39: 4844-58.

Publisher's Version

Last updated on 08/19/2025

Principal Investigator

Principal Investigator Ngoc Uyen Nhi Nguyen, B.Sc., M.Sc., Ph.D.

Internal Medicine/Cardiology, Morsani College of Medicine, University of South Florida

Center for Regenerative Medicine, University of South Florida Health Heart Institute

See also: Principal Investigator

Current Members

Ching-Cheng Hsu, B.Sc., M.Sc., Ph.D.

See also: Current Members